Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
23 Leser
Artikel bewerten:
(0)

Montefiore and Einstein Researchers Receive $1.17 Million Grant to Develop Comparative Effectiveness Research Center

Funds to support research focused on underserved populations

NEW YORK, Nov. 20, 2013 /PRNewswire-USNewswire/ -- The New York State Department of Health has awarded Montefiore Medical Center a $1.17 million grant to support the Center for Comparative Effectiveness Research, a joint project between Montefiore and Albert Einstein College of Medicine of Yeshiva University. The funds from the Empire Clinical Research Investigator Program (ECRIP) will allow Montefiore and Einstein to further generate synergy among its clinical researchers who are engaged in diverse areas of research to compare the effectiveness of different prevention, screening and treatment options for economically underserved populations.

(Logo: http://photos.prnewswire.com/prnh/20120531/DC16559LOGO)

"We are honored to receive this grant and are committed to furthering our academic community goals to facilitate extensive research collaboration focused on comparative effectiveness," said Julia Arnsten, M.D., M.P.H., chief of the division of general internal medicine at Montefiore and Einstein and professor of medicine, psychiatry & behavioral sciences, and epidemiology & population health at Einstein. "This innovative model, based on research, allows us to develop novel diagnostic and treatment options and, in parallel, quickly bring new advances directly to patient care."

The grant allows Montefiore and Einstein to focus on growing the Center for Comparative Effectiveness Research, which was established earlier this year by Dr. Arnsten with the strong support of Brian Currie, M.D., M.P.H., Einstein's assistant dean for clinical research at Montefiore and professor of clinical medicine and clinical epidemiology & population health at Einstein. A portion of the funds will be used to recruit new faculty with expertise in comparative effective research studies as well as clinicians and scientists with expertise in analyzing clinical data. Funds also will be used to award pilot grants focused on comparative effectiveness research for current faculty and clinicians and to support essential data programming capabilities.

"The diverse patient population we serve in the Bronx has been largely excluded from the clinical and comparative effectiveness research that has essentially determined which drugs to use and how people are treated," said Dr. Arnsten. "Our Center hopes to contribute to the understanding of how therapies impact different groups so as to better direct - and customize - patient care."

The grant awarded to Montefiore is part of more than $17.2 million in funding that was given to 31 academic medical institutions across the state to help train physician researchers working on clinical research projects, ranging from the prevention of obesity to treatments for glaucoma. Funds help to cover the costs of physicians in training fellowships and the associated costs to conduct clinical research. Once ECRIP fellows conclude their training through this program, they will be well prepared to apply for National Institutes of Health and other federal research funding. These awards will help train more than 100 physician researchers over the next two years.

"The Empire Clinical Research Investigator Program provides essential support to hospitals across the state for training physicians in clinical research and improving the detection and treatment of diseases," said Governor Andrew M. Cuomo. "These awards also help position New York's hospitals as international leaders in biomedicine, attracting top physicians and medical students and elevating our state's standing for future federal research funds. But most of all, this program enhances the quality of health care statewide which will help create healthier and stronger communities for years to come."

About Albert Einstein College of Medicine of Yeshiva University
Albert Einstein College of Medicine of Yeshiva University is one of the nation's premier centers for research, medical education and clinical investigation. During the 2013-2014 academic year, Einstein is home to 734 M.D. students, 236 Ph.D. students, 106 students in the combined M.D./Ph.D. program, and 353 postdoctoral research fellows. The College of Medicine has more than 2,000 full-time faculty members located on the main campus and at its clinical affiliates (http://www.einstein.yu.edu/health/affiliates.asp). In 2013, Einstein received more than $155 million in awards from the NIH. This includes the funding of major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore Medical Center, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Through its extensive affiliation network involving Montefiore, Jacobi Medical Center-Einstein's founding hospital, and five other hospital systems in the Bronx, Manhattan, Long Island and Brooklyn, Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States. For more information, please visit www.einstein.yu.edu, read our blog, followus on Twitter, like us on Facebook, and view us on YouTube.

About Montefiore Medical Center
As the University Hospital for Albert Einstein College of Medicine, Montefiore is a premier academic medical center nationally renowned for its clinical excellence, scientific discovery and commitment to its community. Recognized among the top hospitals nationally and regionally by U.S. News & World Report, Montefiore provides compassionate, patient- and family-centered care and educates the healthcare professionals of tomorrow. The Children's Hospital at Montefiore is consistently named in U.S. News' "America's Best Children's Hospitals," and is second among those in the New York metro area. With four hospitals, 1,491 beds and 90,000 annual admissions, Montefiore is an integrated health system seamlessly linked by advanced technology. State-of-the-art primary and specialty care is provided through a network of more than 130 locations across the region, including the largest school health program in the nation and a home health program. Montefiore's partnership with Einstein advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. The medical center derives its inspiration for excellence from its patients and community, and continues to be on the frontlines of developing innovative approaches to care. For more information please visit www.montefiore.org and www.montekids.org. Followus on Twitter; like us on Facebook; view us on YouTube.

SOURCEAlbert Einstein College of Medicine

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2013 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.